- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Marksans Pharma Limited — Updates, 05-02-2026: Press Release
05-02-2026 | 02:05 pm
05-02-2026 | 02:05 pm
Marksans Pharma strengthened global footprint via new subsidiaries in Europe and Canada. Q3FY26 revenue grew 10.6% YoY to Rs. 754.4 Cr, with EBITDA up 23.2% to Rs. 160.7 Cr and margin expanding to 21.3%. Performance driven by US/UK and new launches.
No comments yet. Be the first to comment!